97 related articles for article (PubMed ID: 19887826)
1. Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights.
Capelli I; Lerario S; Ciurli F; Berti GM; Aiello V; Provenzano M; La Manna G
Expert Opin Investig Drugs; 2024 May; 33(5):469-484. PubMed ID: 38618918
[TBL] [Abstract][Full Text] [Related]
2. Function follows form: the quest for the best prognostic imaging biomarker in ADPKD.
Kistler AD
Kidney Int; 2023 Aug; 104(2):239-241. PubMed ID: 37479385
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-37: a new therapeutic target in autosomal dominant polycystic kidney disease.
Yang B; Crowley SD
Kidney Int; 2024 Apr; 105(4):661-663. PubMed ID: 38519230
[TBL] [Abstract][Full Text] [Related]
4. Renal Hemodynamic and Functional Changes in Patients with ADPKD.
Ishii R; Kai H; Nakajima K; Harada T; Akiyama T; Okada E; Tsunoda R; Usui T; Mase K; Morito N; Saito C; Usui J; Yamagata K
Kidney360; 2024 May; 5(5):724-731. PubMed ID: 38511865
[TBL] [Abstract][Full Text] [Related]
5. Novel Potential Therapeutic Targets in Autosomal Dominant Polycystic Kidney Disease from the Perspective of Cell Polarity and Fibrosis.
Ahn Y; Park JH
Biomol Ther (Seoul); 2024 May; 32(3):291-300. PubMed ID: 38589290
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, risk factors and disease knowledge of polycystic kidney disease in Pakistan.
Zahid R; Akram M; Rafique E
Int J Immunopathol Pharmacol; 2020; 34():2058738420966083. PubMed ID: 33125856
[TBL] [Abstract][Full Text] [Related]
7. Interventions for preventing the progression of autosomal dominant polycystic kidney disease.
Bolignano D; Palmer SC; Ruospo M; Zoccali C; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010294. PubMed ID: 26171904
[TBL] [Abstract][Full Text] [Related]
8. Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study.
Kistler AD; Serra AL; Siwy J; Poster D; Krauer F; Torres VE; Mrug M; Grantham JJ; Bae KT; Bost JE; Mullen W; Wüthrich RP; Mischak H; Chapman AB
PLoS One; 2013; 8(1):e53016. PubMed ID: 23326375
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway.
Xu T; Wang NS; Fu LL; Ye CY; Yu SQ; Mei CL
Mol Biol Rep; 2012 Jul; 39(7):7743-53. PubMed ID: 22415852
[TBL] [Abstract][Full Text] [Related]
10. Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment.
Halvorson CR; Bremmer MS; Jacobs SC
Int J Nephrol Renovasc Dis; 2010; 3():69-83. PubMed ID: 21694932
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic interventions for autosomal dominant polycystic kidney disease.
Edelstein CL
Nephrol News Issues; 2008 Mar; 22(3):25-6. PubMed ID: 18372677
[TBL] [Abstract][Full Text] [Related]
12. Everolimus in patients with autosomal dominant polycystic kidney disease.
Walz G; Budde K; Mannaa M; Nürnberger J; Wanner C; Sommerer C; Kunzendorf U; Banas B; Hörl WH; Obermüller N; Arns W; Pavenstädt H; Gaedeke J; Büchert M; May C; Gschaidmeier H; Kramer S; Eckardt KU
N Engl J Med; 2010 Aug; 363(9):830-40. PubMed ID: 20581392
[TBL] [Abstract][Full Text] [Related]
13. Emergent early markers of renal progression in autosomal-dominant polycystic kidney disease patients: implications for prevention and treatment.
Helal I; Reed B; Schrier RW
Am J Nephrol; 2012; 36(2):162-7. PubMed ID: 22846584
[TBL] [Abstract][Full Text] [Related]
14. Autosomal dominant polycystic kidney disease: new treatment options and how to test their efficacy.
Wüthrich RP; Serra AL; Kistler AD
Kidney Blood Press Res; 2009; 32(5):380-7. PubMed ID: 19887826
[TBL] [Abstract][Full Text] [Related]
15. [New therapies for ADPKD].
Rathaus M
G Ital Nefrol; 2007; 24(6):526-34. PubMed ID: 18278756
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study.
Stallone G; Infante B; Grandaliano G; Bristogiannis C; Macarini L; Mezzopane D; Bruno F; Montemurno E; Schirinzi A; Sabbatini M; Pisani A; Tataranni T; Schena FP; Gesualdo L
Nephrol Dial Transplant; 2012 Sep; 27(9):3560-7. PubMed ID: 22785114
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
